1. Home
  2. TLSA vs OGI Comparison

TLSA vs OGI Comparison

Compare TLSA & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.15

Market Cap

155.3M

Sector

Health Care

ML Signal

HOLD

Logo Organigram Holdings Inc.

OGI

Organigram Holdings Inc.

HOLD

Current Price

$0.87

Market Cap

152.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLSA
OGI
Founded
2013
2013
Country
United Kingdom
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
155.3M
152.0M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
TLSA
OGI
Price
$1.15
$0.87
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
199.2K
531.0K
Earning Date
05-04-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$20.10
Revenue Next Year
N/A
$13.92
P/E Ratio
N/A
$13.91
Revenue Growth
N/A
N/A
52 Week Low
$1.04
$0.85
52 Week High
$2.60
$2.24

Technical Indicators

Market Signals
Indicator
TLSA
OGI
Relative Strength Index (RSI) 42.58 26.98
Support Level N/A N/A
Resistance Level $1.44 $1.07
Average True Range (ATR) 0.12 0.05
MACD 0.00 -0.00
Stochastic Oscillator 5.89 11.71

Price Performance

Historical Comparison
TLSA
OGI

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

About OGI Organigram Holdings Inc.

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

Share on Social Networks: